Ads
related to: Abbvie- Small Molecules Services
From API to Drug Product
Niche & Complex Small Molecules
- Contact Us
Send Us Your Request
Our Experts Will Contact You
- Biologics Services
From Drug Substance to Drug Product
Upstream & Downstream Processing
- Screening for polymorphs
Download this whitepaper
Learn relevance of this screening
- Small Molecules Services
Search results
AbbVie raises annual profit forecast on strong Skyrizi sales
Reuters via Yahoo Finance· 7 days agoAbbVie raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates ...
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 4 days agoOn Monday, Barclays made an adjustment to its outlook on AbbVie (NYSE:ABBV) shares, reducing the...
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Investing.com· 7 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
AbbVie tries to reassure investors on Humira biosimilar threat
BioPharma Dive via Yahoo Finance· 7 days agoDive Brief: U.S. Humira sales fell 40% year over year during the first three months of 2024, to...
3 Dividend Stocks to Buy and Hold for the Next Decade
Motley Fool via Yahoo Finance· 6 days agoYou only have to find the right stocks worthy of holding for the long term and that pay attractive...
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Reuters· 7 days ago, opens new tab raised its annual profit forecast on Friday after strong sales of its immunology drug Skyrizi and cancer drug Imbruvica helped the company beat Wall Street estimates for the ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 20 hours agoMerck & Co- $30.5bn Merck & Co’s revenues reached $60.1bn in FY 2023, with R&D investments peaking at $30.5bn. Displaying a staggering 126% growth...
Abbvie Inc (ABBV) Becoming More Attractive for Investors – Knox Daily
Knox Daily· 4 days agoAbbvie Inc’s recent filing unveils that its EVP, CHIEF BUS/STRAT OFFICER Donoghoe Nicholas unloaded Company’s shares for reported $3.72 million on Mar 20 ’24. In the deal ...
AbbVie Inc (ABBV) Q1 2024 Earnings: Adjusted EPS Tops Estimates
Guru Focus· 6 days agoOn April 26, 2024, AbbVie Inc (ABBV, Financial) released its 8-K filing, detailing the financial outcomes for the first quarter ended March 31, 2024. The pharmaceutical giant ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 7 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
